Firefox, a protein encoded by circular PVT1, is essential for MYC-driven oncogenesis.
What this study shows
A micropeptide (Firefox/FFX) encoded by the circular RNA circPVT1 stimulates AKT-mTORC1 signaling and cap-dependent translation to sustain MYC protein abundance and transcriptional output. FFX depletion reduces MYC levels and impairs tumor growth in MYC-amplified xenograft models, identifying an mTORC1-linked vulnerability in MYC-driven cancers.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human MYC-amplified cancer cell lines; xenograft mouse models) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human MYC-amplified cancer cell lines; xenograft mouse models |
| Journal | Genes & Development |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.353355.125 · PMID 42618323 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Depletion of the circPVT1-encoded micropeptide (FFX) |
| Target | AKT-mTORC1 signalling and cap-dependent translation, sustaining MYC |
| Model | Human MYC-amplified cancer cell lines; mouse xenografts |
| Effect | The micropeptide sustains AKT-mTORC1 signalling and cap-dependent translation; depleting it lowered MYC protein and impaired xenograft tumour growth. |
In the Atlas
Related topics
More studies on this topic
- The translational landscape of mTOR signalling steers cancer initiation and metastasis (2012)
- mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis (2021)
- mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment (2026)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (2001)
Was this page useful?
Thank you. Your answer was counted anonymously.